Track startup funding.
Find the investors behind it.
A practical, source-backed view of funding rounds, VC firms, and the companies they back — built for faster founder and investor research.
Coverage snapshot
Know what’s in the dataset.
A growing research layer across funds, companies, and source-backed venture coverage.
641
VC firms
Profiles with stage, focus, and contact links.
1,829
Startups
Companies appearing in our funding coverage.
3
Latest signals
Fund closes and rounds in the investment feed.
1,299
Research articles
Analysis, explainers, and market roundups.
Latest funding & fund-close signals
A date-first view of the newest entries in the Venture Capital Tracker feed. Open each item for the full context and source trail.
Bison Ventures closes $160M Fund 2
Firm-announced $160M Fund 2 close for pre-seed through Series B frontier-technology investing. Individual LPs and commitment sizes were not named in the reviewed release. Fund capital, not a startup round or manager-wide AUM.
Dream Labs raises $90M seed for robot foundation models
Company-announced $90M seed led by B Capital alongside Kindred Ventures. Valuation, ownership and exact legal closing date undisclosed. Dream-1 is a research beta not validated for safety-critical use.
XRlabs raises $8.4M seed for surgical intelligence
Company-announced $8.4M seed led by Playground Global with Eka Ventures participating. Separate UK AIRR compute support is excluded; valuation and exact legal closing date were not disclosed.
Research desk
Latest venture capital research
Bison Ventures Closes $160M Fund 2 for Physical-World AI
Bison Ventures confirmed its $160M Fund 2 close. The investment test is funding technical milestones, follow-on needs and commercial deployment.
Read articleXRlabs Raises $8.4M Seed for Surgical Intelligence
Playground Global led XRlabs' $8.4M seed round. The investment case turns on clinical evidence, repeatable integrations and hospital deployment economics.
Read articleProbably Genetic Raises $12M Series A for Rare-Disease Data
Probably Genetic’s reported $12M Series A backs rare-disease data. We separate venture financing from research support and examine data quality and partner economics.
Read articleVessla Raises $3.3M Pre-Seed for Property-Operations AI
Vessla’s $3.3M pre-seed backs AI agents for property operations. The investment test is reliable handoffs, human approvals and repeatable integration economics.
Read articleGo deeper
Research the market your way.
Use the structured pages when you need a shortlist, a company read, or a plain-English answer about how venture capital works.